evaluating Vectibix

Related by string. * EVALUATING . EVALUATED . Evaluated . evaluated . Evaluating : evaluating CK # . When evaluating Antigenics . rigorously evaluated . Intervention Trial Evaluating . evaluating OGX . prospectively evaluated / : permanently discontinue Vectibix . panitumumab Vectibix R . receiving Vectibix monotherapy . panitumumab Vectibix . Vectibix panitumumab . Vectibix monotherapy * *

Related by context. Frequent words. (Click for all words.) 64 metastatic hormone refractory 64 Gemzar ® 63 phase IIb clinical 62 placebo controlled Phase 62 Pivotal Phase 62 relapsed refractory multiple myeloma 61 dose escalation trial 61 prospective multicenter 61 elotuzumab 61 Phase 1b clinical 61 Pivotal Phase III 61 Amrubicin 61 Phase III randomized 61 Phase Ib clinical 61 plus prednisone 61 PRECiSE 60 placebo controlled clinical 60 plus dexamethasone 60 Traficet EN 60 NVA# 60 pharmacokinetics PK 60 phase IIb 60 RIBBON 60 placebo controlled randomized 60 TYKERB 60 active comparator 59 randomized Phase III 59 relapsed multiple myeloma 59 Taxotere R 59 SABCS 59 Phase 1b trial 59 Randomized controlled 59 Multicenter 59 mRCC 59 #th Annual Interscience 59 romidepsin 59 interferon beta 1b 59 HER2 positive metastatic breast 59 multicenter randomized double 59 Epratuzumab 59 TELCYTA 59 plus gemcitabine 58 Phase 2b clinical 58 refractory multiple myeloma 58 DOXIL 58 TORISEL 58 GSK# [001] 58 registrational trial 58 multicenter randomized 58 nab paclitaxel 58 Engerix B 58 Phase 2a clinical 58 rNAPc2 58 docetaxel chemotherapy 58 chlorambucil 58 FOLFIRI 58 liposomal formulation 58 Pivotal Trial 58 blind randomized controlled 58 tanespimycin 58 Chronic Hepatitis C 58 Taxotere ® 58 RADIANT 58 double blinded placebo 58 Phase III Trial 58 carboplatin paclitaxel 58 phase IIa 57 Panzem R 57 NCT# 57 relapsing multiple sclerosis 57 R sorafenib tablets 57 Phase 1b 57 Targretin 57 Pirfenidone 57 pharmacokinetic PK 57 Laquinimod 57 deforolimus 57 Navelbine 57 blinded placebo controlled 57 pivotal Phase III 57 pertuzumab 57 Thrombolysis 56 OncoVEX GM CSF 56 Phase IIa clinical 56 Pegasys ® 56 doripenem 56 blind randomized 56 phase 2a 56 TRITON TIMI 56 IIa trial 56 Chronic Lymphocytic Leukemia 56 CCX# 56 SCH # 56 Clin Infect Dis 56 Clinical Trial Results 56 Phase Ib 56 J Am Coll 56 Fludara 56 patients evaluable 56 diagnosed multiple myeloma 56 Diabetic Macular Edema

Back to home page